Oncology News and Research

RSS
‘Low’ toxicity for phase I cancer trials

‘Low’ toxicity for phase I cancer trials

FDA accepts Teva's NDA for Quartette oral contraceptive

FDA accepts Teva's NDA for Quartette oral contraceptive

Prestigious $2.5M NIH grant to continue work into creation of artificial salivary glands

Prestigious $2.5M NIH grant to continue work into creation of artificial salivary glands

NYU Langone offers chance to participate in lung cancer early detection study

NYU Langone offers chance to participate in lung cancer early detection study

Popular class of diabetes drugs increase risk for bladder cancer

Popular class of diabetes drugs increase risk for bladder cancer

ALS risk markedly lower among alcohol consumers

ALS risk markedly lower among alcohol consumers

Roche MagNA Pure 96 System's CE certified IVD version launched

Roche MagNA Pure 96 System's CE certified IVD version launched

Radiation therapy following lumpectomy may benefit older, early-stage breast cancer patients

Radiation therapy following lumpectomy may benefit older, early-stage breast cancer patients

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Bristol-Myers Squibb completes acquisition of Amylin

Bristol-Myers Squibb completes acquisition of Amylin

FDA approved drug to treat Ph- acute lymphoblastic leukemia

FDA approved drug to treat Ph- acute lymphoblastic leukemia

Worldwide data reveal gaps in elderly eye care

Worldwide data reveal gaps in elderly eye care

Salvage surgery for oropharyngeal cancer needs due consideration

Salvage surgery for oropharyngeal cancer needs due consideration

Loyola to offer new radiotherapy system for cancer patients

Loyola to offer new radiotherapy system for cancer patients

Herceptin® could potentially be delivered via a standard injection

Herceptin® could potentially be delivered via a standard injection

MedPage Today, CollabRx sign license agreement for Oncology Next

MedPage Today, CollabRx sign license agreement for Oncology Next

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Inaugural event of National Women's Survivors Convention to be held in Nashville

Inaugural event of National Women's Survivors Convention to be held in Nashville

Progression-free NSCLC survival boosted by dacomitinib

Progression-free NSCLC survival boosted by dacomitinib

Increases in NSCLC survival 'an artefact of PET assessment'

Increases in NSCLC survival 'an artefact of PET assessment'

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.